|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
From the Department of Cell Differentiation, the
Department of Developmental Genetics, the Institute of Molecular
Embryology and Genetics, and the Animal Resource Center,
Kumamoto University, Kumamoto, Japan; the Second Department of
Pathology, Kumamoto University School of Medicine, Kumamoto, Japan; the
Howard Hughes Medical Institute and Department of Molecular Genetics,
University of Texas Southwestern Medical Center at Dallas, TX;
and Regeneron Pharmaceuticals, Tarrytown, NY.
Although the cellular and molecular mechanisms governing
angiogenesis are only beginning to be understood, signaling through endothelial-restricted receptors, particularly receptor tyrosine kinases, has been shown to play a pivotal role in these events. Recent
reports show that EphB receptor tyrosine kinases and their transmembrane-type ephrin-B2 ligands play essential roles in the embryonic vasculature. These studies suggest that cell-to-cell repellent effects due to bidirectional EphB/ephrin-B2 signaling may be
crucial for vascular development, similar to the mechanism described
for neuronal development. To test this hypothesis, we disrupted the precise expression pattern of EphB/ephrin-B2 in vivo by
generating transgenic (CAGp-ephrin-B2 Tg) mice that express ephrin-B2
under the control of a ubiquitous and constitutive promoter, CMV
enhancer- Angiogenesis, the formation of new vessels from the
pre-existing primary plexus, occurs through several processes: vascular sprouting, branching and pruning, and the differential growth of blood
vessels to form more mature vascular networks.1 These vascular events are required for embryogenesis and are also involved in
several pathophysiologic conditions such as neovascularization in
tumorigenesis, inflammatory disease, and ischemic disease in adulthood.
Although the cellular and molecular mechanisms governing angiogenesis
are only beginning to be understood, signaling through endothelial-restricted receptors, particularly receptor tyrosine kinases (RTKs),2,3 plays a pivotal role in these events. Three subfamilies out of at least 14 RTK subfamilies, vascular endothelial growth factor (VEGF) receptors (VEGFRs), Tie receptors, and
Eph receptors are primarily expressed in the endothelial lining of
blood vessels from embryonic stages to adulthood.3
VEGFs,4-7 ligands for VEGFRs, angiopoietins
(Angs),8 and ligands for Tie-2 receptor9-11
play an essential role in vasculogenesis and angiogenesis. In contrast
to VEGFs and Angs, ephrins, which were initially characterized by their
roles in axon guidance and neuronal patterning,12,13
cannot act as soluble mediators but rather must be membrane-bound to
activate their receptors. This observation indicates that Eph/ephrin
signaling is mediated by cell-to-cell interaction, resulting in
repulsive or attractive signaling.
The recent observation of vascular defects in ephrin-B2 and EphB4
knockout mice strongly suggests that the interaction between the
ephrin-B2 ligand and its cognate EphB4 receptor defines the boundaries
of arterial-venous domains.14,15 Subsequent work demonstrating expression of ephrin-B2 and its cognate EphB receptors in
mesenchymal cells adjacent to vascular endothelial cells (ECs) suggests
an EphB/ephrin-B2 interaction at endothelial-mesenchymal contact
zones.16 Eph receptors and ephrin ligands are divided into
2 broad subclasses, A and B, based on structural homologies and binding
specificities. High redundancy exists within each subclass in terms of
receptor/ligand binding. Ephrin-B ligands are transmembrane proteins
that preferentially bind to receptors of the EphB
subclass.3,13,17 It is notable that ephrin-B ligands not
only activate their respective receptors but also are in turn activated
upon engaging their receptors, as judged by tyrosine phosphorylation of
the ephrin-B cytoplasmic domain.18,19 These findings and
more recent reports20 indicate that ephrins may provide key
bidirectional cues in an obligate cell-to-cell, contact-dependent
fashion in the vascular system. The mechanism of Eph/ephrin-B2
signaling in the vasculature is presently not understood, although
ephrins are repulsive guidance cues for navigating neural cells in the
developing nervous system.12,13,17 More recently, our in
vitro culture analysis demonstrated that EphB4/ephrin-B2 signaling
between endothelial cells and their surrounding stromal cells regulates
the proliferation and mobility of endothelial cells.21
In this study, we conduct functional studies on the role of ephrin-B2
in formation of the vascular system. To examine the role of ephrin-B2
in the vascular system in vivo, we disrupt the complementary
EphB/ephrin-B2 expression pattern by generating transgenic (Tg) mice
that constitutively and ubiquitously express ephrin-B2 under regulation
of the actin promoter (CAGp-ephrin-B2 Tg mice). In these transgenics,
abnormal ephrin-B2 signaling leads to aberrant vessel projection,
abnormal vascular network formation, and defective recruitment of
smooth muscle progenitor cells to the ascending aorta.
Plasmids
For generating inducible ephrin-B2 Tg mice (CAG-IND-ephrin-B2 Tg) in
which ephrin-B2 expression is promoted by Cre-induced loxP
sequence-specific recombination, a transgene containing the CAG-promoter-loxP-blasticidin(bsr)-pA-loxP sites, mouse ephrin-B2 cDNA,
an internal ribosomal entry site (IRES), and a Generation and identification of CAGp-ephrin-B2 transgenic
(Tg) mice
Generation of CAGp-IND-ephrin-B2 Tg mice TT2 embryonic stem (ES) cells (kindly provided by Dr Shinichi Aizawa, Kumamoto University, Japan) were maintained as described previously.26,27 The conditional ephrin-B2 expression vector, CAGp-loxP-bsr-pA-loxP-ephrin-B2-IRES- geo-pA
(CAGp-IND-ephrin-B2), linearized with XhoI, was introduced
into ES cells by electroporation as previously
described.27 Transfected ES cells were screened in 4 µg/mL Blasticidin S (Kaken-Seiyaku) for 5 days. To
evaluate Cre-induced recombination in these ES cells, a CAG-Cre
plasmid28 was introduced into the transfected ES cells, and
X-gal staining and Southern and Western blot analyses were performed,
as described elsewhere.27 Clones without Cre-induced
recombination were used as a control. For further in vivo analysis, 2 mouse lines from each chimeric mouse were generated using independent
ES clones, and F1-generation mice were used in all studies.
Western blotting To detect ephrin-B2 protein in CAG-ephrin-B2 Tg mice, homogenates from murine spleen were prepared as described.29 Cell lysates were cleared by centrifugation for 15 minutes at 15 000g at 4°C, and immunoblotting was performed as previously described.29 Membranes were incubated for 1 hour at room temperature with anti-ephrin-B2 polyclonal antibody (1:300; Santa Cruz Biotechnology, Santa Cruz, CA). Proteins were visualized using the ECL Detection System (Amersham, Arlington Heights, IL).Immunohistochemistry and X-gal staining For whole-mount staining of embryos and ear tissues, specimens were fixed in 4% paraformaldehyde at 4°C for 10 minutes. Anti-platelet endothelial cell adhesion molecule (PECAM)-1 antibody (MEC13.3, rat anti-mouse monoclonal; Pharmingen, San Diego, CA) was used to stain endothelial cells in embryos and tissues. Procedures for immunohistochemistry and X-gal staining have been described elsewhere.30,31 Tissue sections were counterstained with nuclear fast red.Cell culture To examine the recruitment of the vascular smooth muscle progenitor cells into the vessel walls, explants of digested aorta (ascending, arch, and descending portion) were cultured in Dulbecco modified Eagle medium (DMEM; Gibco BRL, Gaithersburg, MD) plus 10% fetal calf serum (FCS; JRH Bioscience, Lenexa, KS) plus 2 mercaptoethanol (ME). After 7days in culture, anti- -smooth
muscle actin antibody conjugated with horseradish peroxidase
(HRP) (Dako Japan, Kyoto, Japan) was used to stain vascular
smooth muscle cells (SMCs). To analyze the growth of vascular SMCs,
cells were harvested after 7days from cultures of digested aorta
explants and 103 SMCs were recultured. After 3, 7, and 12 days in culture, cells were harvested and counted.
Ephrin-B2 is expressed in both arterial endothelial cells and their surrounding mesenchymal cells We analyzed ephrin-B2 expression in embryonic days E11.5 embryos of ephrin-B2 promoter (p)-LacZ heterozygous mice (ephrin-B2LacZ/+),32 in which the lacZ gene is inserted into the ephrin-B2 genomic locus by homologous recombination. X-gal staining revealed that ephrin-B2 was expressed in arterial endothelial cells in the vascular system and broadly in many mesenchymal cells (Figure 1A,B), while Tie-2, which is a vascular endothelial maker, was specifically expressed in endothelial cells of large artery, vein, and vascular networks in Tie-2p-LacZ Tg mice (Figure 1C,D). In the trunk region of E11.5 embryos, intersomitic ephrin-B2 vessels existed between ephrin-B2+
somites and arteries (Figure 1E,F). Moreover, histologic
analysis revealed that ephrin-B2 vessels were sprouted
from the cardinal vein, suggesting that the vessels are vein-expressing
EphB4 receptors. In addition, they existed between
ephrin-B2+ mesenchymal cells and arteries (Figure 1G,I).
These findings suggest that an EphB4/ephrin-B2 interaction in ECs and
surrounding mesenchymal cells may regulate vessel projections.
Generation of CAGp- and CAGp-IND-ephrin-B2 transgenic mice To investigate the role of an EphB/ephrin-B2 interaction in ECs and surrounding mesenchymal cells, we disrupted the complementary pattern of EphB/ephrin-B2 expression by generating Tg mice expressing ephrin-B2 constitutively and ectopically under the regulation of CAG promoter (Figure 2A). Of the 50 mice that survived to 3 weeks of age, 3 transgenic founders were generated as confirmed by polymerase chain reaction (PCR) analysis of genomic DNA (Figure 2B). All 3 founders were bred with wild-type C57BL/6 mice and transmitted the transgene following a Mendelian distribution. To analyze transgene expression in the F1 offspring from each founder, Northern analysis of total ear RNA was performed using mouse ephrin-B2 cDNA as a probe (Figure 2C). An ephrin-B2 transgene of the expected size was observed in 2 lines,12,21 whereas the third line47 was a nonexpressing line.-actin
(1:5000; Sigma, St Louis, MO) blotting on the same membrane
demonstrated equal loading in each lane (data not shown). In addition,
Northern blot analysis of total RNA from various tissues in 8-week-old
mice revealed that the transgene was broadly expressed in both lines 12 and 21 Tg mice, indicating that the broad expression of transgene
disrupted the ephrin-B2 expression pattern seen in wild-type mice (data not shown). Based on these observations, lines 12 and 21 were chosen
for further study, and both showed essentially equivalent phenotypes.
To obtain Tg mice expressing ephrin-B2 inducibly, the vector
pCAG-IND-ephrin-B2 was introduced into ES cells by electroporation. Clones were isolated after positive selection in Blasticidin S, and
genomic DNA was analyzed by Southern blot analysis to select cell lines
with a single-copy integration pattern (Figure
3A). We established 6 independent ES cell
lines carrying a single copy of the vector and subsequently selected 2 ES clones among them. To test the Cre-induced recombination, we deleted
the Blasticidin resistance sequence and allowed ephrin-B2 expression to
occur by electroporation of the vector pCAG-Cre into these 2 ES cells (Figure 3B). As expected, recombination allowed these cells to express
ephrin-B2,
Abnormal vascular structure of the aorta in CAGp-ephrin-B2 Tg mice Two founders (no. 51 and no. 52) (Table 1, Figure 2B) died suddenly as neonates because of a dissecting aneurysm. Although we could not examine ephrin-B2 expression in these lines, the lethality suggests that vascular morphologic phenotypes may be sensitive to ephrin-B2 doses. To investigate this possibility, we analyzed homozygous CAGp-ephrin-B2 Tg (Tg/Tg) mice, which were generated from crosses of both line12 and line 21 mice. Western blotting revealed that Tg/Tg mice expressed twice the level of ephrin-B2 protein than did heterozygous CAGp-ephrin-B2 Tg (Tg/+) mice (Figure 4A). All Tg/Tg mice died of acute aortic dissecting aneurysms at neonatal stages (Figure 4B-F, Table 1). To analyze whether defects existed in vascular structures, we performed histological analyses of the vascular morphology of E19 Tg/Tg, Tg/+, and wild-type littermates. Compared to the vascular structure of Tg/+ and wild-type mice, Tg/Tg mice exhibited a thin vascular wall in the ascending aorta and aortic arch (Figure 4G-H). Furthermore, electron microscope analysis revealed that in Tg/Tg mice, ECs have a flat morphology with a budlike structure, while ECs in Tg/+ and wild-type mice show a round morphology. In addition, SMCs and elastic bands were missing in Tg/Tg mice compared to wild-type mice, and new microvessels were seen in these spaces (Figure 4I-J). This abnormal vasculature was observed in the ascending and arch portions of the aorta, while a normal vascular structure was detected in the descending aorta in Tg/Tg mice. To investigate whether recruitment of SMCs was defective, explants of aorta (ascending, arch, and descending portions) were cultured. In Tg/Tg mice, migrating and proliferating SMCs from explants of ascending (Figure 4K-M) and arch portions (data not shown) of aorta were significantly decreased compared to those of wild-type littermates and Tg/+ mice, while no differences among the 3 groups were observed in cultures from explants from descending aorta (data not shown). To examine whether these findings depend on defects in recruitment of smooth muscle progenitor cells rather than cell growth, identical numbers of SMCs derived from ascending aorta explant cultures of Tg/Tg, Tg/+, and wild-type littermates were recultured, and their growth curves were analyzed. No differences in cell growth were observed among the 3 genotypes (Figure 4N). No defective vascular structures were observed in either Tie-2p-ephrin-B2 Tg mice specifically expressing ephrin-B2 in ECs (Figure 3H) or endothelin promoter-ephrin-B2 Tg mice, which express ephrin-B2 in both ECs and SMCs (our unpublished data, 2001). These results indicate that defective vessel structures seen in ascending and arch portions of aorta are at least associated with failure of smooth muscle progenitor cells to migrate into these regions because of abnormal ephrin-B2 expression.
Regulation of vessel projections by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells To investigate the role of EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells in vascular formation, we compared vascular network formation in CAGp-ephrin-B2 Tg mice to that of Tie-2p-ephrin-B2 Tg mice. In the head region of wild-type embryos, a highly organized vascular system with branches extending from the anterior cardinal vein (ACV) and internal carotid artery (ICA) was observed (Figure 5A), and ephrin-B2 expression was restricted to the artery (Figure 1B). Notably, CAGp-ephrin-B2 Tg mice exhibited dilation and truncation of venous vessels (Figure 5B,C). In contrast, these abnormal findings were not observed in Tie-2p-ephrin-B2 Tg mice, while some Tie-2p-ephrin-B2 Tg mice exhibited cranial hemorrhages (Figure 5G,H). As the trunk region of wild-type embryos at E11.5 contains intersomitic vessels arranged in segments located between somite boundaries (Figure 5D, Figure 1E,F), we analyzed the arrangement of intersomitic vessels in CAGp-ephrin-B2 Tg mice. As predicted, the intersomitic vessels were disorganized and penetrated aberrantly into neighboring somites in CAGp-ephrin-B2 Tg mice (Figure 5E,F), while no abnormality of somite boundaries was detected. In contrast, these abnormal vessel projections were not observed in Tie-2p-ephrin-B2 Tg mice (Figure 5I).
Regulatory roles of ephrin-B2 in network formation of capillary-sized vessels To analyze the role of EphB/ephrin-B2 signaling in network formation of capillary vessels, we investigated the pattern of ephrin-B2 expression in capillary-sized networks of 14-day-old mice (P14) using the ephrin-B2LacZ/+ mice. Sporadic ephrin-B2 was expressed in capillary networks, while ephrin-B2 expression was uniform in arterioles (Figure 6A,B). These findings suggest that the signaling of EphB/ephrin-B2 may be important for capillary formation. To examine this hypothesis, we performed a lectin binding assay34,35 to analyze capillary network formation in both CAGp- and Tie-2p-ephrin-B2 Tg mice. Capillary network formation in both CAGp- and Tie-2p-ephrin-B2 Tg mice was markedly decreased compared to that of wild-type littermates, in which capillary formation was dense (Figure 6C-E). An ephrin-B2 site in capillary is
essential to bind with EphB4+ capillary, because
EphB4+ capillary cannot bind to ephrin-B2+
capillary because of a repulsive effect. Here, we propose a
model for capillary network formation that is regulated by
EphB/ephrin-B2 signaling (Figure 6F).
The ephrin-B2 ligand that signals through cell-surface EphB receptors is itself a transmembrane protein, suggesting that ephrin-B2 signaling may play an important role in cell-to-cell contact interaction. The phenotypes of mice lacking ephrin-B2, EphB4, and EphB2/B3 indicate that ephrin-B2 and its cognate EphB receptors are essential for early vascular development.14-16,20 However, the early embryonic lethality of these knockout mice has prevented further analysis of the role of EphB/ephrin-B2 signaling in the vasculature. In this study, we focused on defining the role of EphB/ephrin-B2 interaction between ECs and mesenchymal cells in the formation of the vascular system. During embryogenesis, ephrin-B2 is broadly expressed in arterial endothelial cells, the surrounding mesenchyme, somites, and neurons,36 while the expression pattern of Eph receptors is still controversial. Although initial work focused on the reciprocal distribution of EphB4 in the venous ECs of the embryo, recent findings indicate that other EphB receptors are widely expressed and could have specific ligand-receptor interactions to arterial ephrin-B2.15,16,36 These observations suggest that EphB/ephrin-B2 may regulate precise vessel projections through interactions between ECs and surrounding cells during embryogenesis, like an axonal guidance in neurons is regulated by Eph/ephrin signaling by providing a repulsive or attractive cue.37,38 To test this hypothesis, we disrupted the precise expression pattern of EphB/ephrin-B2 in vivo by generating Tg mice that express ephrin-B2 under the control of a ubiquitous and constitutive promoter, CAGp. These mice displayed an abnormal segmental arrangement of intersomitic vessels, while such anomalies were not observed in Tie-2p-ephrin-B2 Tg mice, in which ephrin-B2 was overexpressed in only vascular ECs. This finding suggests that surrounding cells expressing ephrin-B2 ectopically alter the migration of ECs expressing EphB receptors into the intersomitic region where ephrin-B2 expression is normally absent. Similarly, ectopic expression of ephrin-B ligands leads to aberrant intersomitic vein projection in Xenopus laevis,39 and disorganized intersomitic vessels are seen in mouse mutants in EphB415 and ephrin-B2.16,20 These previous findings also supported our hypothesis that precise guidance of EphB4+ vascular ECs occurs because of repellent cues mediated by ephrin-B2+ cells. However, whether Eph/ephrin signaling in the vascular system parallels mechanisms observed in the nervous system remains to be determined. Further elucidation of the molecular mechanism how repulsive or attractive cell-to-cell interactions control vascular formation is essential. As vessel projection is the initial event in many pathologic conditions, it may provide new strategies in (anti)angiogenic treatment. Although EphB4/ephrin-B2 interaction is known to be involved in defining boundaries between arteries and veins, the mechanism of capillary formation is not clear. More recently, we analyzed the function of EphB4/ephrin-B2 signals using in vitro stromal cells and a para-aortic splanchnopleura coculture system.21 This demonstrated that the proliferation and migration of ECs were suppressed when the ephrin-B2+ cells and EphB4+ cells contact each other at the boundary in vitro vascular network formation. In this study, we found a sporadic pattern of ephrin-B2 expression in cells involved in capillary formation in vivo. In addition, our morphological analysis reveals defects in capillary-sized arterial-venous boundary formation in the circulatory system of both CAGp- and Tie-2p-ephrin-B2 Tg mice. This indicates that disruption of the precise expression pattern of EphB/ephrin-B2 in the circulatory system caused the failure of capillary formation, suggesting the important role of EphB/ephrin-B2 signaling at arterial-venous boundary formation. Some Tie-2p-ephrin-B2 Tg mice also showed intracerebral bleeding, which may have been caused by the abnormalities of capillary formation. In the nervous system, repulsive cues promoted by contact between Eph+ cells and ephrin+ cells induce withdrawal of the ephrin+ axons.40 If similar contact-mediated repellent effects exist in the vascular system, such sporadic ephrin-B2 expression in capillaries could mediate fusion of distinct types of endothelial cells and play a role in network formation. Indeed, more recently we found that EphB4+ ECs were inhibited to spread and grow on the ephrin-B2-Fc-coated dishes (K.H. et al, manuscript in preparation). Given this set of findings, precise ephrin-B2 expression is essential for capillary formation. Neural crest cells migrate along specific pathways to the branchial
arches and differentiate into vascular SMCs in the vascular system.41,42 Only in CAGp-ephrin-B2 Tg mice was
defective recruitment of smooth muscle progenitor cells in the
ascending aorta and aortic arch detected, suggesting that disruption of
normal EphB/ephrin-B2 signaling induced by ubiquitous ephrin-B2
expression caused abnormal migration of neural crest cells. A similar
conclusion has been reached for trunk neural crest migration. Krull et
al43 demonstrated that the migration of neural crest cells
expressing EphB3 is regulated by ephrin-B1+ cells in the
trunk region. In their studies, the addition of soluble ephrin-B1
disrupted the patterned migration of neural crest cells in a whole-
trunk explant. It is notable that these effects were dependent on the
dose of ephrin-B ligand. In addition, Wang et al37
demonstrated that neural crest cell migration was precisely regulated
by EphB/ephrin-B2 repulsive effect on the stripes where
ephrin-B2+ and ephrin-B2 In summary, our in vivo analysis demonstrated that EphB/ephrin-B2 signaling between ECs and their surrounding mesenchymal cells regulates the vessel formation through promoting or suppressing the proliferation and migratory activity of both ECs and SMCs.
We thank Dr John G. Flanagan for providing us with full-length ephrinB2 cDNA; Ms T. Keida, M. Tokushima, and I. Kawasaki for experimental assistance; and Dr A. Hirata for technical support in the lectin-staining experiment.
Submitted September 12, 2001; accepted March 25, 2002.
Supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research from Japan Society for promotion of Science; and a grant from the Takeda science foundation.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Toshio Suda, The Sakaguchi Laboratory, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan; e-mail: sudato{at}sc.itc.keio.ac.jp.
1. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674[CrossRef][Medline] [Order article via Infotrieve].
2.
Hanahan D.
Signaling vascular morphogenesis and maintenance.
Science.
1997;277:48-50
3.
Gale NW, Yancopoulos GD.
Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development.
Genes and Dev.
1999;13:1055-1066 4. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature. 1995;376:66-70[CrossRef][Medline] [Order article via Infotrieve]. 5. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in FLK-1-deficient mice. Nature. 1995;376:62-66[CrossRef][Medline] [Order article via Infotrieve]. 6. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435-439[CrossRef][Medline] [Order article via Infotrieve]. 7. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442[CrossRef][Medline] [Order article via Infotrieve].
8.
Davis S, Gale NW, Aldrich TH, et al.
Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity.
Science.
1994;266:816-819 9. Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML. Tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene. 1992;7:1471-1480[Medline] [Order article via Infotrieve].
10.
Partanen J, Armstrong E, Makela TP, et al.
A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.
Mol Cell Biol.
1992;12:1698-1707 11. Iwama A, Hamaguchi I, Hashiyama M, Murayama M, Yasunaga K, Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Comm. 1993;195:301-309[CrossRef][Medline] [Order article via Infotrieve]. 12. Gale NW, Yancopoulos GD. Ephrins and their receptors: a repulsive topic? Cell Tissue Res. 1997;290:227-242[CrossRef][Medline] [Order article via Infotrieve]. 13. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998;21:309-345[CrossRef][Medline] [Order article via Infotrieve]. 14. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor EphB4. Cell. 1998;93:741-753[CrossRef][Medline] [Order article via Infotrieve]. 15. Gerety SS, Wang HU, Chen Z-F, Anderson DJ. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999;4:403-414[CrossRef][Medline] [Order article via Infotrieve].
16.
Adams RH, Wilkinson GA, Weiss C, et al.
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.
Genes and Dev.
1999;13:295-306 17. Gale NW, Holland SJ, Valenzuela DM, et al. Eph receptors and ligands comprise two major specificity subclasses, and are reciprocally compartmentalized during embryogenesis. Neuron. 1996;17:9-19[CrossRef][Medline] [Order article via Infotrieve]. 18. Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. Nature. 1996;383:722-725[CrossRef][Medline] [Order article via Infotrieve].
19.
Brückner K, Pasquale EB, Klein R.
Tyrosine phosphorylation of transmembrane ligands for Eph receptors.
Science.
1997;275:1640-1643 20. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R. The cytoplasmic domain of the ligand ephrin-B2 is required for vascular morphogenesis but not cranial neural crest. Cell. 2001;104:57-69[CrossRef][Medline] [Order article via Infotrieve].
21.
Zhang X-Q, Takakura N, Oike Y, et al.
Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2+ endothelial cells.
Blood.
2001;98:1028-1037 22. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193-199[CrossRef][Medline] [Order article via Infotrieve].
23.
Mountford P, Zevnik B, Duwel A, et al.
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.
Proc Natl Acad Sci U S A.
1994;91:4303-4307
24.
Araki K, Araki M, Yamamura K.
Targeting integration of DNA using mutant loxP sites in embryonic stem cells.
Nucleic Acids Res.
1997;25:868-872 25. Yagi T, Tokunaga T, Furuta Y, et al. A novel ES cell line, TT2, with high germline-differentiating potency. Anal Biochem. 1993;214:70-76[CrossRef][Medline] [Order article via Infotrieve].
26.
Oike Y, Hata A, Mamiya T, et al.
Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implication for a dominant-negative mechanism.
Hum Mol Genet.
1999;8:387-396
27.
Araki K, Imaizumi T, Okuyama K, Oike Y, Yamamura K.
Efficiency of recombination by Cre transient expression in embryonic stem cells: comparison of various promoters.
J Biochem.
1997;122:977-982 28. Hogan B, Beddington R, Costantini F, Lacy E. Manipulating the mouse embryo: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1994. 29. Iwama A, Yamaguchi N, Suda T. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family. EMBO J. 1996;15:5866-5875[Medline] [Order article via Infotrieve]. 30. Takakura N, Huang X, Naruse T, et al. Critical role of the TIE2 endothelial cell receptor in the development of definitive hematopoiesis. Immunity. 1998;9:677-686[CrossRef][Medline] [Order article via Infotrieve].
31.
Hamada K, Oike Y, Takakura N, et al.
VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis.
Blood.
2000;96:3793-3800 32. Gale NW, Baluk P, Pan L, et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol. 2001;230:151-160[CrossRef][Medline] [Order article via Infotrieve]. 33. Kisanuki YY, Hammer RE, Miyazaki J, Williams SC, Richardson JA, Yanagisawa M. Tie-2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol. 2001;230:230-242[CrossRef][Medline] [Order article via Infotrieve]. 34. Thurston G, Baluk P, Hirata A, McDonald DM. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol. 1996;271:H2547-H2562[Medline] [Order article via Infotrieve].
35.
Thurston G, Suri C, Smith K, et al.
Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.
Science.
1999;286:2511-2514 36. Gale NW, Baluk P, Pan L, et al. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth muscle cells. Dev Biol. 2001;230:151-160[CrossRef][Medline] [Order article via Infotrieve]. 37. Wang HU, Anderson DJ. Eph family transmembrane ligands can mediate repulsive guidance of trunk neural crest migration and motor axon outgrowth. Neuron. 1997;18:383-396[CrossRef][Medline] [Order article via Infotrieve]. 38. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development. 1999;126:2033-2044[Abstract]. 39. Helbling PM, Saulnier DME, Brandli AW. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis. Development. 2000;127:269-278[Abstract].
40.
Hattori M, Osterfield M, Flanagan JG.
Regulated cleavage of a contact-mediated axon repellent.
Science.
2000;289:1360-1365 41. Smith A, Robinson V, Patel K, Wilkinson DG. The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of brachial neural crest cells. Curr Biol. 1997;7:561-570[CrossRef][Medline] [Order article via Infotrieve]. 42. Yamauchi Y, Abe K, Mantani A, et al. A novel transgenic technique that allows specific marking of the neural crest cells lineage in mice. Dev Biol. 1999;212:191-203[CrossRef][Medline] [Order article via Infotrieve]. 43. Krull CE, Lansford R, Gale NW, et al. Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr Biol. 1997;7:571-580[CrossRef][Medline] [Order article via Infotrieve].
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  A. Pennisi, W. Ling, X. Li, S. Khan, J. D. Shaughnessy Jr, B. Barlogie, and S. Yaccoby The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth Blood, August 27, 2009; 114(9): 1803 - 1812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fukai, H. Yokote, R. Yamanaka, T. Arao, K. Nishio, and T. Itakura EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line Mol. Cancer Ther., September 1, 2008; 7(9): 2768 - 2778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, H. Dong, B. Wang, S. Zhu, and B. A. Croy Dynamic Changes Occur in Patterns of Endometrial EFNB2/EPHB4 Expression During the Period of Spiral Arterial Modification in Mice Biol Reprod, September 1, 2008; 79(3): 450 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Korff, J. Braun, D. Pfaff, H. G. Augustin, and M. Hecker Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment Blood, July 1, 2008; 112(1): 73 - 81. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lackmann and A. W. Boyd Eph, a Protein Family Coming of Age: More Confusion, Insight, or Complexity? Sci. Signal., April 15, 2008; 1(15): re2 - re2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. T. Carmichael Themes and Strategies for Studying the Biology of Stroke Recovery in the Poststroke Epoch Stroke, April 1, 2008; 39(4): 1380 - 1388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schmidt, K. Brixius, and W. Bloch Endothelial Precursor Cell Migration During Vasculogenesis Circ. Res., July 20, 2007; 101(2): 125 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.E. Ferguson III, R. W. Kelley, and C. Patterson Mechanisms of Endothelial Differentiation in Embryonic Vasculogenesis Arterioscler Thromb Vasc Biol, November 1, 2005; 25(11): 2246 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O. Zamora, M. H. Davies, S. R. Planck, J. T. Rosenbaum, and M. R. Powers Soluble Forms of EphrinB2 and EphB4 Reduce Retinal Neovascularization in a Model of Proliferative Retinopathy Invest. Ophthalmol. Vis. Sci., June 1, 2005; 46(6): 2175 - 2182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Ivanov, A. A. Steiner, A. C. Scheck, and A. A. Romanovsky Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats Physiol Genomics, April 14, 2005; 21(2): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Morikawa and P. Cserjesi Extra-embryonic vasculature development is regulated by the transcription factor HAND1 Development, May 1, 2004; 131(9): 2195 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ehrbar, V. G. Djonov, C. Schnell, S. A. Tschanz, G. Martiny-Baron, U. Schenk, J. Wood, P. H. Burri, J. A. Hubbell, and A. H. Zisch Cell-Demanded Liberation of VEGF121 From Fibrin Implants Induces Local and Controlled Blood Vessel Growth Circ. Res., April 30, 2004; 94(8): 1124 - 1132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Noren, M. Lu, A. L. Freeman, M. Koolpe, and E. B. Pasquale Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth PNAS, April 13, 2004; 101(15): 5583 - 5588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. T. Vaszar, T. Nishimura, J. D. Storey, G. Zhao, D. Qiu, J. L. Faul, R. G. Pearl, and P. N. Kao Longitudinal transcriptional analysis of developing neointimal vascular occlusion and pulmonary hypertension in rats Physiol Genomics, April 13, 2004; 17(2): 150 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Hausman and R. L. Richardson Adipose tissue angiogenesis J Anim Sci, March 1, 2004; 82(3): 925 - 934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Albrecht, A. M. Chinnaiyan, S. Varambally, C. Kumar-Sinha, T. R. Barrette, J. V. Sarma, and P. A. Ward C5a-Induced Gene Expression in Human Umbilical Vein Endothelial Cells Am. J. Pathol., March 1, 2004; 164(3): 849 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hafner, G. Schmitz, S. Meyer, F. Bataille, P. Hau, T. Langmann, W. Dietmaier, M. Landthaler, and T. Vogt Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and Cancers Clin. Chem., March 1, 2004; 50(3): 490 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Huang, S. Z. Soffer, E. S. Kim, K. W. McCrudden, J. Huang, T. New, C. A. Manley, W. Middlesworth, K. O'Toole, D. J. Yamashiro, et al. Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis Mol. Cancer Res., January 1, 2004; 2(1): 36 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lai, B. L. Bohnsack, K. Niederreither, and K. K. Hirschi Retinoic acid regulates endothelial cell proliferation during vasculogenesis Development, December 29, 2003; 130(26): 6465 - 6474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fuller, T. Korff, A. Kilian, G. Dandekar, and H. G. Augustin Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells J. Cell Sci., June 15, 2003; 116(12): 2461 - 2470. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
